As part of Clariane’s Refinancing Plan, Belgian press are reporting that Rothschild are mandated to sell its Belgian and Dutch facilities. Clariane has
Read MoreA share buyback of up to €252m over the next 18 months is an eye-catching headline, but we expect the actual buyback outlay will be much smaller and back-ended. The buyback authorisation figure is sized on 10% of outstanding shares at €10 per share, bu
Read More
Tullow had already given us the headline numbers about FY23, so our main focus was production guidance for FY24 and beyond. Guidance is 62-68k boepd, up from
Read MoreToday’s announcement of a restructuring project for the promissory note loans (under StaRUG) reflects the difficulty in extending the term of these loans. If 75% of the
Read MoreBoparan will be refinancing its SSNs in 2024, so it is an opportune time to upgrade the CFO as work begins to sell a story to Investors. The article suggests a
Read MoreThe recapitalisation of INTU SGS is due to be completed in the next 4-6 weeks, following a Scheme of Arrangement Sanction hearing on the
Read MoreInvestors are familiar with the name and the strategy of sending any excess cash to the parent, so the downgrade at VMED (from BB- to B+) will only have
Read More
Please find our updated analysis of Oriflame here.
So the Felix household bought a blender the other day. It’s a great way to fix up smoothies in no time and it’s striking to see the ingredients blend to the point where they are no longer recognisable. In a way, Oriflame results in the last six months have been strikingly
Read MoreHeadline numbers from Friday’s release are strong, with the Gross Profit margin inflated by a reversal of the IAS 37 impact. Despite this reversal from Q1 23, the Gross Profit margin
Read MoreDouglas are looking to IPO as soon as this month with a full refinancing of the cap stack. Interestingly though, CVC are planning to inject another €300m in the
Read More
Please speak to the analyst.
Read More
The FY23 numbers were ahead of our expectations in terms of EBITDA and cash generation. The construction order book is also healthy. Total cash was
Read More
Y23 results were ahead of our model and above the median of analyst consensus. Overall, we see the results as a positive development for the Tech Solutions business, and the end game for
Read MoreAnd here it is: Lowell’s bragging slide this morning shows Pro Forma Cash EBITDA Leverage of 2.7x. Even collections are presented in a positive
Read MoreAtos have appointed three new directors, two at the behest of its largest shareholder Onepoint (11.4%). David Layani, founder and chief executive of Onepoint and
Read MoreAMS announced last night the loss of a cornerstone contract for its microLED strategy, rumoured to be Apple. This is a major setback for the Company and genuinely calls into
Read More